
|Articles|June 1, 2010
- Applied Clinical Trials-06-01-2010
- Volume 0
- Issue 0
Applied Clinical Trials Digital Edition - June 2010
GLOBAL TRIALS : New Survey Baselines Global Sites Keys to Success in China Budgeting for Global Trials European Ethics Committees CRO/SPONSOR : Think About the Drug Label First LABS : 3-Prong Model for CV Safety Immune Response Screens a Necessity eCLINICAL : ePRO?s Tipping Point Also in this issue : FDA?s New Risk Approach to Site Inspections, EMA Speaks to Stem Cell Research, Mother Lode of Latent Research Data
Advertisement
Articles in this issue
about 16 years ago
Biosimilars Make Headwayabout 16 years ago
Business and News Update June 2010about 16 years ago
Electronic Integration Costsabout 16 years ago
Strategic Immunogenicity Testingabout 16 years ago
ePRO vs. Paperabout 16 years ago
Today's Global Site Landscapeabout 16 years ago
Changing Medicines, Changing Rulesabout 16 years ago
Ethics Diversity Persistsabout 16 years ago
Mastering Currency Fluctuationabout 16 years ago
Just Breathe: COPD, Asthma FutureAdvertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Finalizes Three Guidances to Broaden Cancer Clinical Trial Eligibility
2
Beyond Compliance: YPrime's Paulo Limgenco on Moving ESG From Reporting to Real Business Value
3
ACT Brief: Data Pipeline Standardization for Real-Time Analysis, Sponsor Accountability Beyond Contracts, and Autoimmune Pipeline Expansion
4
ACT Brief: Inspection Readiness Throughout Lifecycle, AI Churn and Operational Discipline, and Global Trial Stakeholder Alignment
5




